CHEN Liangshan. Analysis on distribution of pathogenic bacteria and drug sensitivity in patients with urogenital tract infection[J]. Journal of Clinical Medicine in Practice, 2020, 24(22): 66-69. DOI: 10.7619/jcmp.202022019
Citation: CHEN Liangshan. Analysis on distribution of pathogenic bacteria and drug sensitivity in patients with urogenital tract infection[J]. Journal of Clinical Medicine in Practice, 2020, 24(22): 66-69. DOI: 10.7619/jcmp.202022019

Analysis on distribution of pathogenic bacteria and drug sensitivity in patients with urogenital tract infection

More Information
  • Received Date: September 24, 2020
  • Available Online: December 21, 2020
  • Published Date: December 02, 2020
  • Objective To observe the distribution of pathogenic bacteria and drug sensitivity of patients with urogenital tract infection. Methods A total of 600 patients with urogenital tract infection were selected as study subjects, and urethral discharge of male patients and cervical secretions of female patients were collected, pathogen culture and drug sensitivity test were conducted in a sterile environment, the distribution of pathogenic bacteria and drug resistance were observed and analyzed. Results A total of 1 562 strains of pathogenic bacteria were isolated from 600 patients with urogenital tract infection, including 1 103 strains of Mycoplasma and 459 strains. Ureaplasma urealyticum(Uu)and Mycoplasma hominis(Mh)were main Mycoplasma infection, accounting for 33.03%(516/1 562)and 14.40%(225/1 562), respectively; Enterobacteriaceae and Enterococcus were the main bacteria, accounting for 11.65%(182/1 562)and 8.58%(134/1 562), respectively. The susceptibilities test showed that Uu and Mh were highly sensitive to josamycin, doxycycline, and minocycline, while their sensitivities to erythromycin and ofloxacin were low. Enterobacteriaceae was highly sensitive to imipenem, meroppenem, piperacillin/tazobactam, while was lowly sensitive to amoxicillin and ticacillin. Enterococcus was highly sensitive to vancomycin and tekoranin, while was lowly sensitive to erythromycin. Conclusion Mycoplasma infection is the main infection source in patients with urogenital tract infection, and bacteria infection is also presented. Therefore, clinical trials should be strengthened the susceptibility results of pathogenic bacteria in infected patients, so as to reasonably select antibacterial drugs.
  • 王海燕. 2013—2015年天津市武清区中医医院女性泌尿生殖道感染的病原菌分布及耐药性分析[J]. 现代药物与临床, 2016, 31(8): 1296-1299.
    冯登礼, 王瑗, 葛敏. 2016—2017年连云港市妇幼保健院女性泌尿生殖道感染的病原菌分布及耐药性分析[J]. 现代药物与临床, 2018, 33(11): 3060-3063.
    李仕伟, 傅雷, 刘艳秋, 等. 泌尿生殖道支原体感染及耐药性分析[J]. 现代预防医学, 2015, 42(4): 762-763.
    HORNER P, DONDERS G, CUSINI M, et al. Should we be testing for urogenital Mycoplasma hominis, Ureaplasma parvum and Ureaplasma urealyticum in men and women- a position statement from the European STI Guidelines Editorial Board[J]. J Eur Acad Dermatol Venereol, 2018, 32(11): 1845-1851.
    裴显峰. 女性泌尿生殖道感染患者衣原体检测支原体培养及药敏分析[J]. 当代医学, 2016, 22(11): 63-64.
    晋兴, 武爱荣, 黄波, 等. 用纸片扩散法和微量稀释法进行药物敏感性测定的比较[J]. 国际检验医学杂志, 2014, 35(3): 322-324.
    张雅薇, 王辉. 2015年CLSI M100-S25主要更新内容介绍[J]. 中华检验医学杂志, 2015, 38(4): 229-232.
    MIYAKE M, OHNISHI K, HORI S, et al. Mycoplasma genitalium infection and chronic inflammation in human prostate cancer: detection using prostatectomy and needle biopsy specimens[J]. Cells, 2019, 8(3): 212-215.
    胡森安, 艾红红, 吴惠强, 等. 1708例泌尿生殖道支原体感染检测及药敏分析[J]. 国际检验医学杂志, 2017, 38(4): 530-532.
    DEBORDE M, PEREYRE S, PUGES M, et al. High prevalence of Mycoplasma genitalium infection and macrolide resistance in patients enrolled in HIV pre-exposure prophylaxis program[J]. Med Mal Infect, 2019, 49(5): 347-349.
    潘长清, 王丹, 邓艳梅, 等. 2014—2016年绵阳市中心医院女性泌尿生殖道感染的病原菌分布及耐药性分析[J]. 现代药物与临床, 2016, 31(9): 1505-1508.
    JENSEN JS, CUSINI M, GOMBERG M, et al. 2016 European guideline on Mycoplasma genitalium infections[J]. J Eur Acad Dermatol Venereol, 2016, 30(10): 1650-1656.
    龚娅, 段德令, 何宗忠, 等. 19530例泌尿生殖道感染患者支原体感染及药敏结果分析[J]. 重庆医学, 2015, 44(25): 3539-3541.
    王鹏, 泰淑红, 邵艳, 等. 泌尿生殖道支原体感染状况及药敏结果分析[J]. 实用检验医师杂志, 2015, 7(2): 100-103.
    丁玲加提, 姚楠, 邵惠. 新疆克拉玛依地区泌尿生殖道支原体感染的病原分型及药敏分析[J]. 实用皮肤病学杂志, 2015, 8(5): 357-359.
    杨时瀚, 罗育豪, 蔡锦楠, 等. 广东潮汕地区3785例泌尿生殖道感染患者支原体分布及药敏分析[J]. 临床皮肤科杂志, 2019, 48(11): 659-661.
    石月萍, 周海燕, 王国英. 女性泌尿生殖道支原体、衣原体及淋球菌感染的结果分析[J]. 中国卫生检验杂志, 2019, 29(20): 2517-2519

    , 2523.
    邓佳, 陈君, 周颖, 等. 性病门诊泌尿生殖道感染者病原菌检测及药敏分析[J]. 中华男科学杂志, 2019, 25(10): 950-952.
  • Cited by

    Periodical cited type(9)

    1. 李易晨,柏承文. 免疫微生态肠内营养方案可改善重症急性胰腺炎患者肠道菌群和预后. 内科急危重症杂志. 2023(01): 26-29 .
    2. 江浩. 益生菌对重症急性胰腺炎患者免疫功能及血清TRF、PA、ALB、Hb水平的影响. 现代医学与健康研究电子杂志. 2021(03): 61-63 .
    3. 尚鸳鸳. 早期肠内营养支持对重症急性胰腺炎患者的临床疗效及安全性探讨. 临床医学工程. 2021(09): 1259-1260 .
    4. 薛静,李胜,谢文贤,秦健,缪婷,卢翠洁,王振,王浩. 益生菌联合早期肠内营养治疗重症急性胰腺炎临床疗效的Meta分析. 中国微生态学杂志. 2021(12): 1413-1419 .
    5. 廖健宏. 益生菌联合早期肠内营养对急性胰腺炎患者血浆白蛋白、C反应蛋白、淀粉酶及体质量等指标的影响研究. 现代消化及介入诊疗. 2020(03): 364-366 .
    6. 樊周沛,尹明明,李颖霞,温洪涛. 早期肠内营养对结肠癌患者术后康复进程和并发症的影响. 河南医学研究. 2020(18): 3300-3302 .
    7. 黄建,江钟立. 早期肠内营养重构肠道微生态促进缺血性脑卒中康复的研究. 现代消化及介入诊疗. 2019(04): 398-401 .
    8. 李明. 肠道微生态在急性胰腺炎发病和治疗中的应用研究进展. 世界最新医学信息文摘. 2019(58): 52-53 .
    9. 张紫盈,范正论. 早期肠内营养联合肠外营养对重症急性胰腺炎患者的临床研究. 临床医药文献电子杂志. 2019(94): 9 .

    Other cited types(3)

Catalog

    Article views PDF downloads Cited by(12)

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return